Literature DB >> 9583761

Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy.

M Ertas1, A Sagduyu, N Arac, B Uludag, C Ertekin.   

Abstract

Levodopa has been used to treat some painful conditions and found to be effective in neuropathic pain due to herpes zoster in a double-blind study. From our anecdotal observations about the efficacy of levodopa on diabetic neuropathic pain, we designed a double-blind placebo-controlled study to test levodopa in painful diabetic neuropathy. Twenty-five out-patients with painful symmetrical diabetic polyneuropathy were admitted to the study. Fourteen patients were given 100 mg levodopa plus 25 mg benserazide to be taken three times per day for 28 days. Eleven patients were given identical placebo capsules. A blinded neurologist evaluated the patients clinically and performed Visual Analogue Scale (VAS) measurement every week from day 0 to day 28. The results seemed promising and levodopa may be a choice for the control of pain in neuropathy for which we do not have many alternative treatments.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9583761     DOI: 10.1016/s0304-3959(98)00003-7

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  21 in total

Review 1.  Combination pharmacotherapy for the treatment of neuropathic pain in adults.

Authors:  Luis Enrique Chaparro; Philip J Wiffen; R Andrew Moore; Ian Gilron
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

Review 2.  Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction.

Authors:  Johanna M Jarcho; Emeran A Mayer; Ziyue Karen Jiang; Natasha A Feier; Edythe D London
Journal:  Pain       Date:  2012-03-03       Impact factor: 6.961

Review 3.  Diabetic neuropathy: clinical manifestations and current treatments.

Authors:  Brian C Callaghan; Hsinlin T Cheng; Catherine L Stables; Andrea L Smith; Eva L Feldman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

4.  Computational repositioning and preclinical validation of pentamidine for renal cell cancer.

Authors:  Luiz Fernando Zerbini; Manoj K Bhasin; Jaira F de Vasconcellos; Juliano D Paccez; Xuesong Gu; Andrew L Kung; Towia A Libermann
Journal:  Mol Cancer Ther       Date:  2014-05-01       Impact factor: 6.261

5.  Direct inhibition of substantia gelatinosa neurones in the rat spinal cord by activation of dopamine D2-like receptors.

Authors:  Akihiro Tamae; Terumasa Nakatsuka; Kohei Koga; Go Kato; Hidemasa Furue; Toshihiko Katafuchi; Megumu Yoshimura
Journal:  J Physiol       Date:  2005-06-23       Impact factor: 5.182

Review 6.  Diabetic painful neuropathy: current and future treatment options.

Authors:  M Sam Chong; Joan Hester
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors.

Authors:  Matthew F Lazenka; Kelen C Freitas; Sydney Henck; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2017-04-14       Impact factor: 4.030

Review 8.  Effects of treatments for symptoms of painful diabetic neuropathy: systematic review.

Authors:  Man-chun Wong; Joanne W Y Chung; Thomas K S Wong
Journal:  BMJ       Date:  2007-06-11

Review 9.  Frontostriatal Gating of Tinnitus and Chronic Pain.

Authors:  Josef P Rauschecker; Elisabeth S May; Audrey Maudoux; Markus Ploner
Journal:  Trends Cogn Sci       Date:  2015-10       Impact factor: 20.229

10.  D2 Receptors in the Periaqueductal Gray/Dorsal Raphe Modulate Peripheral Inflammatory Hyperalgesia via the Rostral Ventral Medulla.

Authors:  Luiz F Ferrari; JunZhu Pei; Michael Zickella; Charles Rey; Jacqueline Zickella; Anna Ramirez; Norman E Taylor
Journal:  Neuroscience       Date:  2021-04-04       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.